Abstract
The COVID-19 pandemic and the move to telemedicine for office-based opioid treatment have made the practice of routine urine drug tests (UDT) obsolete. In this commentary we discuss how COVID-19 has demonstrated the limited usefulness and possible harms of routine UDT. We propose that practitioners should stop using routine UDT and instead use targeted UDT, paired with clinical reasoning, as part of a patient-centered approach to care.
Original language | English (US) |
---|---|
Article number | 108155 |
Journal | Journal of Substance Abuse Treatment |
Volume | 120 |
DOIs | |
State | Published - Jan 2021 |
ASJC Scopus subject areas
- Phychiatric Mental Health
- Medicine (miscellaneous)
- Clinical Psychology
- Psychiatry and Mental health